SCHEMBL16626427

SCHEMBL16626427

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Nc3ccc(OC)cc3OC(F)(F)F)ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.40
PPARG P37231 1/20 0.38
PPARD Q03181 1/20 0.38
PPARA Q07869 1/20 0.38
FBP1 P09467 1/20 0.37
MKNK2 Q9HBH9 1/20 0.37
NAMPT P43490 2/20 0.37
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
DHODH Q02127 1/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
PIK3CG P48736 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618642 0.99 HTR6 (0.40) HTR6PPARGPPARDPPARAFBP1
SCHEMBL16626439 0.94 LMNA (0.39) HTR6PPARGPPARDPPARANAMPT
Hydrochloric Acid SCHEMBL16619117 0.93 LMNA (0.38) HTR6PPARGPPARDPPARANAMPT
SCHEMBL17971524 0.92 HTR6 (0.43) HTR6FBP1NAMPTCHRNB4CHRNA3
SCHEMBL16626416 0.90 ALPL (0.42) HTR6NAMPTLMNAHTTSMN1; SMN2
SCHEMBL16626487 0.90 HTR6 (0.39) HTR6PPARGPPARDPPARAFBP1
Hydrochloric Acid SCHEMBL16618861 0.90 ALPL (0.41) HTR6NAMPTLMNAHTTSMN1; SMN2
SCHEMBL17971525 0.89 HTR6 (0.41) HTR6FBP1CHRNB4CHRNA3CNR1
Hydrochloric Acid SCHEMBL16619661 0.89 HTR6 (0.39) HTR6PPARGPPARDPPARAMKNK2
Hydrochloric Acid SCHEMBL16618959 0.89 HTR6 (0.41) HTR6FBP1CHRNB4CHRNA3CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI HTR6 166/4885PPARG 437/4885PPARD 570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.